Insider · CIK 0001892297
Quan Anh Vu
Files at MNPR (Monopar Therapeutics). First filing Dec 29, 2025, latest Dec 29, 2025.
In brief
Quan Anh Vu files SEC Form 4 as CFO at MNPR (Monopar Therapeutics). Since Dec 29, 2025, Quan Anh Vu has reported 1 open-market buy worth $105k and 0 open-market sells worth $0, the latest filed on Dec 29, 2025.
A track record needs three past buys with six months of prices behind them; Quan Anh Vu has 0, so none is measured yet.
The newest scored trade: bought $105k of MNPR on Dec 26, 2025, filed Dec 29, 2025, scored 48 (moderate). In the last 12 months: 1 buy worth $105k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MNPR: Monopar Therapeutics
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | MNPRbuy Monopar Therapeutics | $105k 1,500 shares | - | +213% from low-33% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | MNPR Monopar Therapeutics | MOption exercise Common Stock | +614 | - | - | 2,835 | 11 d ago |
| Sep 30, 2026 | MNPR Monopar Therapeutics | FTax withholding Common Stock | -180 | $79.67 | $14k | 2,655 | 11 d ago |
| Sep 30, 2026 | MNPR Monopar Therapeutics | MOption exercise Restricted Stock Unitderivative | -614 | $0.00 | $0 | 7,984 | 11 d ago |
| Jun 30, 2026 | MNPR Monopar Therapeutics | MOption exercise Common Stock | +1,228 | - | - | 2,728 | Jul 2, 2026 |
| Jun 30, 2026 | MNPR Monopar Therapeutics | FTax withholding Common Stock | -507 | $92.59 | $47k | 2,221 | Jul 2, 2026 |
| Jun 30, 2026 | MNPR Monopar Therapeutics | MOption exercise Restricted Stock Unitderivative | -1,228 | $0.00 | $0 | 8,598 | Jul 2, 2026 |
| Dec 26, 2025 | MNPR Monopar Therapeutics | POpen-market purchase Common Stock | +1,500 | $69.95 | $105k | 1,500 | Dec 29, 2025 |
| Dec 2, 2025 | MNPR Monopar Therapeutics | AGrant or award Stock Optionsderivative | +7,135 | $0.00 | $0 | 7,135 | Dec 8, 2025 |
| Dec 2, 2025 | MNPR Monopar Therapeutics | AGrant or award Restricted Stock Unitsderivative | +9,826 | $0.00 | $0 | 9,826 | Dec 8, 2025 |
Questions about Quan Anh Vu
Answered from the filings on this page, as of the latest one.
Is Quan Anh Vu buying or selling?
In the last 12 months Quan Anh Vu reported 1 open-market buy worth $105k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $105k of MNPR on Dec 26, 2025. Grants, option exercises and tax withholding are not counted.
How did Quan Anh Vu's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Quan Anh Vu has 0.
Where does Quan Anh Vu file Form 4?
Quan Anh Vu has filed Form 4 at MNPR (Monopar Therapeutics) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.